TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS

DISCLOSED HEREIN IS A METHOD OF TREATING A PATIENT SUFFERING A MYOCARDIAL INFARCTION, PARTICULARLY AN ACUTE MYOCARDIAL INFARCTION, OR OF REDUCING AN ADVERSE CONSEQUENCE OF A MYOCARDIAL INFARCTION IN A PATIENT COMPRISING ADMINISTERING AN ANTAGONIST OF TGF-ß TO THE PATIENT DURING THE ACUTE STAGE OF TH...

Full description

Saved in:
Bibliographic Details
Main Authors GREGORY, RICHARD C., JR, LONNING, SCOTT, KUDEJ, AMELIA B, AKITA, GEOFFREY Y
Format Patent
LanguageEnglish
Published 28.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract DISCLOSED HEREIN IS A METHOD OF TREATING A PATIENT SUFFERING A MYOCARDIAL INFARCTION, PARTICULARLY AN ACUTE MYOCARDIAL INFARCTION, OR OF REDUCING AN ADVERSE CONSEQUENCE OF A MYOCARDIAL INFARCTION IN A PATIENT COMPRISING ADMINISTERING AN ANTAGONIST OF TGF-ß TO THE PATIENT DURING THE ACUTE STAGE OF THE MYOCARDIAL INFARCTION.
AbstractList DISCLOSED HEREIN IS A METHOD OF TREATING A PATIENT SUFFERING A MYOCARDIAL INFARCTION, PARTICULARLY AN ACUTE MYOCARDIAL INFARCTION, OR OF REDUCING AN ADVERSE CONSEQUENCE OF A MYOCARDIAL INFARCTION IN A PATIENT COMPRISING ADMINISTERING AN ANTAGONIST OF TGF-ß TO THE PATIENT DURING THE ACUTE STAGE OF THE MYOCARDIAL INFARCTION.
Author KUDEJ, AMELIA B
LONNING, SCOTT
AKITA, GEOFFREY Y
GREGORY, RICHARD C., JR
Author_xml – fullname: GREGORY, RICHARD C., JR
– fullname: LONNING, SCOTT
– fullname: KUDEJ, AMELIA B
– fullname: AKITA, GEOFFREY Y
BookMark eNrjYmDJy89L5WSwDglydQzxdfULUfB3U_CN9Hd2DHLxdPRR8PRzcwxyDvH091MIDfb0c1cIcXfTPTxfwdEvxNHd388zOCSYh4E1LTGnOJUXSnMzyLm5hjh76KYW5MenFhckJqfmpZbE-0Yampkamhk4GhNUAABR9Crm
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID MY165160A
GroupedDBID EVB
ID FETCH-epo_espacenet_MY165160A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:55:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MY165160A3
Notes Application Number: MY2013PI00675
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180228&DB=EPODOC&CC=MY&NR=165160A
ParticipantIDs epo_espacenet_MY165160A
PublicationCentury 2000
PublicationDate 20180228
PublicationDateYYYYMMDD 2018-02-28
PublicationDate_xml – month: 02
  year: 2018
  text: 20180228
  day: 28
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies GENZYME CORPORATION
RelatedCompanies_xml – name: GENZYME CORPORATION
Score 3.1300654
Snippet DISCLOSED HEREIN IS A METHOD OF TREATING A PATIENT SUFFERING A MYOCARDIAL INFARCTION, PARTICULARLY AN ACUTE MYOCARDIAL INFARCTION, OR OF REDUCING AN ADVERSE...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180228&DB=EPODOC&locale=&CC=MY&NR=165160A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANxvsx5YB6q-i7q1CFsnbdhmg7dQFtp6ntUsSlm1gRP4cfwx8jCR1w2S1KJMux5DhO_H0GuNELJc0KlqZq-VyTDZONMqcoZIUaHV1xqDOnHOAcRtbgyXiYmJMGvKyxMIIn9EOQIzKPypm_V-K8Xv49YvmitnJ1m72yqcV9QFxfqrNjTmemdSS_6_ZGsR97kue54VSKEle1TNVS8BZsszu0LTK25y6HpCz_x5PgAHZGTFRZHUKDli3Y89Zt11qwG9a_3WxYO97qCO5I0sOEE--jOEDhNPZw4g_xIxpGAU5EIQjiHTT6iPQD-esT4YjgfhwNx2R8DO2gR7yBzLSY_e53Fk5rbfUTaJaLkp4BUs2OTWla2LqR8UoWx1ItamfzPNeplqrGOZxuEHKxceUS9rnJfgDaV9Cs3t7pNQuxVdYW5vkG7nR9NA
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbjPdj5IB6q-h7rVCFsnbdCms7dQFtp2ntUsSlm1gRP4cfwx8jKR1w2S1KJMux5DhO_H0GuFEzaZZkLE1V0rkiajobJVaWiRLVTFWyqDWnHOAchEb_SXsY6-MavKyxMCVP6EdJjsg8KmX-XpTn9fLvEcstaytXt8krm1rce8R2hSo75nRmiim4Hbs7jNzIERzHDiZCGNuyocuGhLdgm92vzTJPeu5wSMryfzzx9mFnyETlxQHUaN6EhrNuu9aE3aD67WbDyvFWh3BH4i4mnHgfRR4KJpGDY9fHA-SHHo7LQhDEO2j0EOl54tcnwiHBvSj0R2R0BC2vS5y-yLSY_u53GkwqbdVjqOeLnJ4CknWzTeksa6tawitZLEM2aDuZp6lKlZmsncHJBiHnG1euodEnwWA68MPHC9jj5vsBa19CvXh7p1cs3BZJqzTVN_T6gCQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TREATMENT+OF+MYOCARDIAL+INFARCTION+USING+TGF-%C3%9F+ANTAGONISTS&rft.inventor=GREGORY%2C+RICHARD+C.%2C+JR&rft.inventor=LONNING%2C+SCOTT&rft.inventor=KUDEJ%2C+AMELIA+B&rft.inventor=AKITA%2C+GEOFFREY+Y&rft.date=2018-02-28&rft.externalDBID=A&rft.externalDocID=MY165160A